Archive - June 2018
Roche agrees $2.4bn takeover of genomics player Foundation
NHS could save £7bn with greater diagnostics use
Pharma demands guarantees for UK sector deal
FDA Issues Complete Response Letter for Duobrii (halobetasol propionate and tazarotene) Lotion
Freeline raises £88m to accelerate haemophilia gene therapy
Phase III success for Janssen’s esketamine in treatment-resistant depression
Roche snaps up rest of Foundation Medicine for $2.4bn
US regulators reject Valeant’s Duobrii